T1	CHEM 79 98	alfa 1-antitripsina
#1	AnnotatorNotes T1	C0002191; alpha 1-antitrypsin; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T2	PROC 105 115	prevención
#2	AnnotatorNotes T2	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T3	PROC 187 224	trasplante de células hematopoyéticas
T4	ANAT 201 224	células hematopoyéticas
#3	AnnotatorNotes T4	C2323499; Hematopoietic cell; Cell
T5	PROC 247 346	Estudio de fase 2/3, multicéntrico, aleatorizado, con doble enmascaramiento, controlado con placebo
T6	PROC 352 386	evaluar la seguridad y la eficacia
#4	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity
T7	CHEM 393 412	alfa 1-antitripsina
#5	AnnotatorNotes T7	C0002191; alpha 1-antitrypsin; Amino Acid, Peptide, or Protein · Biologically Active Substance · Pharmacologic Substance
T8	PROC 419 429	prevención
#6	AnnotatorNotes T8	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T9	PROC 501 538	trasplante de células hematopoyéticas
T10	ANAT 515 538	células hematopoyéticas
#7	AnnotatorNotes T10	C2323499; Hematopoietic cell; Cell
T11	DISO 586 622	enfermedad de injerto-contra-huésped
T12	DISO 630 642	complicación
#8	AnnotatorNotes T12	C0009566; Complication; Pathologic Function
T13	PROC 683 721	transplante de células hematopoyéticas
T14	DISO 788 824	enfermedad de injerto-contra-huésped
T15	PROC 930 941	tratamiento
#9	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	DISO 978 986	leucemia
#10	AnnotatorNotes T16	C0023418; leukemia; Neoplastic Process
T17	DISO 991 998	linfoma
#11	AnnotatorNotes T17	C0024299; Lymphoma; Neoplastic Process
T18	DISO 1004 1020	mieloma múltiple
#12	AnnotatorNotes T18	C0026764; Multiple Myeloma; Neoplastic Process
T19	PROC 1025 1030	Pauta
#13	AnnotatorNotes T19	C0935576; treatment guideline; Therapeutic or Preventive Procedure
T20	PROC 1034 1065	acondicionamiento mieloablativo
#14	AnnotatorNotes T20	C4319756; Myeloablative Conditioning; Therapeutic or Preventive Procedure
T21	PROC 1140 1180	Trasplante con reducción de linfocitos T
T22	ANAT 1168 1180	linfocitos T
#15	AnnotatorNotes T22	C0039194; T-Lymphocyte; Cell
T23	PROC 1202 1213	tratamiento
#16	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	CHEM 1274 1298	globulina antitimocítica
#17	AnnotatorNotes T24	C0003442; lymphocyte immune globulin, anti-thymocyte globulin; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T25	CHEM 1306 1317	alemtuzumab
#18	AnnotatorNotes T25	C0383429; alemtuzumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T26	PROC 1342 1383	Trasplante de sangre del cordón umbilical
T27	ANAT 1356 1383	sangre del cordón umbilical
#19	AnnotatorNotes T27	C0162371; Umbilical Cord Blood; Body Substance
T28	DISO 122 158	enfermedad de injerto-contra-huésped
T29	ANAT 136 143	injerto
#20	AnnotatorNotes T29	C0332835; Transplanted tissue; Tissue
T30	DISO 436 472	enfermedad de injerto-contra-huésped
T31	ANAT 450 457	injerto
#21	AnnotatorNotes T31	C0332835; Transplanted tissue; Tissue
T32	ANAT 738 745	órganos
#22	AnnotatorNotes T32	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T33	ANAT 600 607	injerto
#23	AnnotatorNotes T33	C0332835; Transplanted tissue; Tissue
T34	ANAT 698 721	células hematopoyéticas
#24	AnnotatorNotes T34	C2323499; Hematopoietic cell; Cell
T35	ANAT 802 809	injerto
#25	AnnotatorNotes T35	C0332835; Transplanted tissue; Tissue
T36	DISO 945 969	neoplasias hematológicas
T37	CHEM 1218 1246	anticuerpos antilinfocitos T
T38	CHEM 1300 1303	GAT
#26	AnnotatorNotes T38	C0003442; lymphocyte immune globulin, anti-thymocyte globulin; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T39	Date 13 17	2018
T41	LIVB 151 158	huésped
#27	AnnotatorNotes T41	C1167395; Host (organism); Organism
T42	LIVB 162 171	pacientes
#28	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T44	LIVB 465 472	huésped
#29	AnnotatorNotes T44	C1167395; Host (organism); Organism
T45	LIVB 476 485	pacientes
#30	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T47	LIVB 615 622	huésped
#31	AnnotatorNotes T47	C1167395; Host (organism); Organism
T48	LIVB 750 758	paciente
#32	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T50	LIVB 817 824	huésped
#33	AnnotatorNotes T50	C1167395; Host (organism); Organism
T51	LIVB 854 890	Sujetos de sexo masculino o femenino
#34	AnnotatorNotes T51	C0681850; Study Subject; Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T52	Age 892 900	≥12 años
T54	PHYS 209 224	hematopoyéticas
#35	AnnotatorNotes T54	C0018951; Hematopoiesis; Organ or Tissue Function
T55	PHYS 523 538	hematopoyéticas
#36	AnnotatorNotes T55	C0018951; Hematopoiesis; Organ or Tissue Function
T56	PHYS 706 721	hematopoyéticas
#37	AnnotatorNotes T56	C0018951; Hematopoiesis; Organ or Tissue Function
#38	AnnotatorNotes T36	C0376545; Hematologic Neoplasms; Neoplastic Process 
#39	AnnotatorNotes T28	C0018133; Graft-vs-Host Disease; Disease or Syndrome 
#40	AnnotatorNotes T30	C0018133; Graft-vs-Host Disease; Disease or Syndrome 
#41	AnnotatorNotes T11	C0018133; Graft-vs-Host Disease; Disease or Syndrome 
#42	AnnotatorNotes T14	C0018133; Graft-vs-Host Disease; Disease or Syndrome 
#43	AnnotatorNotes T5	C1519042; Phase II/III Trial; Research Activity + C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#44	AnnotatorNotes T26	C0935850; Umbilical Cord Blood Transplantation; Therapeutic or Preventive Procedure
T40	PROC 918 921	THB
#45	AnnotatorNotes T40	[hematopoietic cell transplant]
T43	PROC 1104 1107	THB
A1	Status T43 History_of
#46	AnnotatorNotes T43	[hematopoietic cell transplant]
R2	Experiences Arg1:T50 Arg2:T14	
R3	Has_Age Arg1:T51 Arg2:T52	
R4	Experiences Arg1:T51 Arg2:T40	
R5	Experiences Arg1:T51 Arg2:T15	
R6	Experiences Arg1:T51 Arg2:T36	
R7	Experiences Arg1:T51 Arg2:T16	
R8	Experiences Arg1:T51 Arg2:T17	
R9	Experiences Arg1:T51 Arg2:T18	
T46	Quantifier_or_Qualifier 1066 1074	prevista
#47	AnnotatorNotes T46	C1301732; Planned; Functional Concept
R10	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T46	
T49	Quantifier_or_Qualifier 1108 1116	autólogo
A2	Status T49 History_of
#48	AnnotatorNotes T49	C0439859; Autologous (qualifier value); Qualitative Concept
R11	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T49	
T53	Quantifier_or_Qualifier 1119 1126	alógeno
A3	Status T53 History_of
#49	AnnotatorNotes T53	C1515895; Allogeneic; Qualitative Concept
R12	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T53	
R13	Used_for Arg1:T37 Arg2:T23	
T57	Quantifier_or_Qualifier 1247 1254	ex vivo
#50	AnnotatorNotes T57	C2348480; ex vivo; Functional Concept
R14	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T57	
T58	Quantifier_or_Qualifier 1187 1195	previsto
#51	AnnotatorNotes T58	C1301732; Planned; Functional Concept
T59	Quantifier_or_Qualifier 1384 1392	previsto
#52	AnnotatorNotes T59	C1301732; Planned; Functional Concept
R16	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T59	
R17	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T58	
T60	Quantifier_or_Qualifier 1257 1264	in vivo
#53	AnnotatorNotes T60	C1515655; In Vivo; Spatial Concept
R18	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T60	
R19	Used_for Arg1:T24 Arg2:T23	
R20	Used_for Arg1:T38 Arg2:T23	
R21	Used_for Arg1:T25 Arg2:T23	
R22	Used_for Arg1:T1 Arg2:T2	
R23	Before Arg1:T2 Arg2:T28	
R1	Experiences Arg1:T41 Arg2:T28	
R24	Experiences Arg1:T41 Arg2:T1	
R25	Experiences Arg1:T42 Arg2:T28	
R26	Experiences Arg1:T42 Arg2:T3	
#54	AnnotatorNotes T3	C0472699; Hemopoietic stem cell transplant; Therapeutic or Preventive Procedure
R29	Experiences Arg1:T42 Arg2:T54	
R30	Used_for Arg1:T7 Arg2:T8	
R31	Experiences Arg1:T44 Arg2:T7	
R32	Experiences Arg1:T45 Arg2:T7	
R33	Experiences Arg1:T45 Arg2:T9	
R34	Experiences Arg1:T45 Arg2:T55	
#55	AnnotatorNotes T9	C0472699; Hemopoietic stem cell transplant; Therapeutic or Preventive Procedure
R36	Experiences Arg1:T44 Arg2:T30	
R37	Experiences Arg1:T45 Arg2:T30	
R38	Before Arg1:T8 Arg2:T30	
R39	Before Arg1:T3 Arg2:T28	
R40	Before Arg1:T9 Arg2:T30	
R41	After Arg1:T11 Arg2:T13	
R42	After Arg1:T12 Arg2:T13	
#56	AnnotatorNotes T13	C0472699; Hemopoietic stem cell transplant; Therapeutic or Preventive Procedure
R46	Experiences Arg1:T47 Arg2:T11	
R47	Experiences Arg1:T47 Arg2:T12	
R48	Experiences Arg1:T47 Arg2:T13	
R49	Experiences Arg1:T44 Arg2:T9	
R50	Experiences Arg1:T41 Arg2:T3	
R51	Experiences Arg1:T48 Arg2:T11	
R52	Experiences Arg1:T48 Arg2:T13	
R53	Experiences Arg1:T48 Arg2:T12	
R54	Experiences Arg1:T48 Arg2:T56	
R15	Experiences Arg1:T45 Arg2:T8	
R27	Experiences Arg1:T44 Arg2:T8	
R28	Experiences Arg1:T44 Arg2:T55	
R35	Experiences Arg1:T47 Arg2:T56	
#57	AnnotatorNotes T21	C5685877; transfusion of T-cell depleted hematopoietic stem cell; Therapeutic or Preventive Procedure (?)
T61	PROC 1330 1337	estudio
#58	AnnotatorNotes T61	C0008976; Clinical Trials; Research Activity
R43	Overlap Arg1:T21 Arg2:T61	
R44	Overlap Arg1:T23 Arg2:T61	
A4	Experiencer T41 Patient
A5	Experiencer T42 Patient
A6	Experiencer T44 Patient
A7	Experiencer T45 Patient
A8	Experiencer T47 Patient
A9	Experiencer T48 Patient
A10	Experiencer T50 Patient
A11	Experiencer T51 Patient
A12	Status T20 Future
A13	Status T19 Future
A14	Status T26 Future
A15	Status T23 Future
A16	Status T37 Future
A17	Status T24 Future
A18	Status T38 Future
A19	Status T25 Future
